Van Cauwenberge H - Search Results

1

Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy.

Corhay JL, Dang DN, Van Cauwenberge H, Louis R. Corhay JL, et al. Among authors: van cauwenberge h. Int J Chron Obstruct Pulmon Dis. 2014;9:27-39. doi: 10.2147/COPD.S52012. Epub 2013 Dec 16. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24368884 Free PMC article. Review.

2

Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.

Calmes D, Graff S, Maes N, Frix AN, Thys M, Bonhomme O, Berg J, Debruche M, Gester F, Henket M, Paulus V, Duysinx B, Heinen V, Dang DN, Paulus A, Quaedvlieg V, Vaillant F, Van Cauwenberge H, Malaise M, Gilbert A, Ghuysen A, Gillet P, Moutschen M, Misset B, Sibille A, Guiot J, Corhay JL, Louis R, Schleich F. Calmes D, et al. Among authors: van cauwenberge h. J Allergy Clin Immunol Pract. 2021 Jan;9(1):160-169. doi: 10.1016/j.jaip.2020.09.044. Epub 2020 Oct 7. J Allergy Clin Immunol Pract. 2021. PMID: 33038592 Free PMC article.

3

[Fixed combination of budesonide, formoterol, glycopyrronium for the treatment of severe COPD : Trixeo Aerosphere®].

Louis R, Bonhomme O, Heinen V, Nguyen D, Van Cauwenberge H, Corhay JL. Louis R, et al. Among authors: van cauwenberge h. Rev Med Liege. 2022 Apr;77(4):244-248. Rev Med Liege. 2022. PMID: 35389009 Free article. French.

4

[Telemonitoring of severe COPD patients].

Van Cauwenberge H, Delroualle A, Hans B, Nguyen Dang D, Corhay JL, Louis R, Gillet P. Van Cauwenberge H, et al. Rev Med Liege. 2019 Nov;74(11):566-571. Rev Med Liege. 2019. PMID: 31729844 Free article. French.

5

[Feasibility and effectiveness study of a simplified mobile self-education and self-monitoring application for patients with severe chronic obstructive pulmonary disease].

Duquenne JB, Corhay JL, Louis R, Van Cauwenberge H. Duquenne JB, et al. Among authors: van cauwenberge h. Rev Med Liege. 2022 Feb;77(2):110-117. Rev Med Liege. 2022. PMID: 35143131 Free article. French.

6

[Long-term oxygen therapy: mortality rate, short-term predictive mortality factors].

Van Cauwenberge H, Thonnard AS, Nguyen Dang D, Corhay JL, Louis R. Van Cauwenberge H, et al. Rev Mal Respir. 2018 Nov;35(9):939-947. doi: 10.1016/j.rmr.2018.09.001. Epub 2018 Sep 25. Rev Mal Respir. 2018. PMID: 30266456 French.

7

Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic.

Guiot J, Henket M, Frix AN, Delvaux M, Denis A, Giltay L, Thys M, Gester F, Moutschen M, Corhay JL, Louis R; COVID-19 clinical investigators of the CHU de Liège. Guiot J, et al. Respir Investig. 2020 Nov;58(6):437-439. doi: 10.1016/j.resinv.2020.08.006. Epub 2020 Sep 19. Respir Investig. 2020. PMID: 32978099 Free PMC article.

8

YKL-40 as a new promising prognostic marker of severity in COVID infection.

Schoneveld L, Ladang A, Henket M, Frix AN, Cavalier E, Guiot J; COVID-19 clinical investigators of the CHU de Liège. Schoneveld L, et al. Crit Care. 2021 Feb 16;25(1):66. doi: 10.1186/s13054-020-03383-7. Crit Care. 2021. PMID: 33593373 Free PMC article. No abstract available.

9

[Update in non-union treatment].

Van Cauwenberge H, Hauzeur JP, Gillet P. Van Cauwenberge H, et al. Rev Med Liege. 2007 May-Jun;62(5-6):344-51. Rev Med Liege. 2007. PMID: 17725205 Free article. Review. French.

10

[Aspirin, an always current drug].

Van Cauwenberge H. Van Cauwenberge H. Rev Med Liege. 1996 Jan;51(1):7-18. Rev Med Liege. 1996. PMID: 8701141 Review. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page